obovatol has been researched along with Invasiveness, Neoplasm in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, X; Duan, M; Ren, G; Sun, S; Zhang, J; Zhang, Y; Zheng, Y | 1 |
1 other study(ies) available for obovatol and Invasiveness, Neoplasm
Article | Year |
---|---|
Obovatol inhibits the growth and aggressiveness of tongue squamous cell carcinoma through regulation of the EGF‑mediated JAK‑STAT signaling pathway.
Topics: Animals; Antigens, CD; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Cadherins; Carcinoma, Squamous Cell; CDC2 Protein Kinase; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase 2; Epidermal Growth Factor; Fibronectins; Gene Expression Regulation, Neoplastic; Humans; Janus Kinases; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Phenyl Ethers; Signal Transduction; STAT Transcription Factors; Tongue Neoplasms; Vimentin; Xenograft Model Antitumor Assays | 2018 |